Kevin Leon Cook - Jun 21, 2021 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role
Chief Financial Officer
Signature
/s/ Grant Harbert, as Attorney-in-Fact
Stock symbol
LCTX
Transactions as of
Jun 21, 2021
Transactions value $
$0
Form type
4
Date filed
7/1/2021, 04:21 PM
Next filing
Feb 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LCTX Employee Stock Option (right to buy) Award $0 +750K $0.00 750K Jun 21, 2021 Common Shares 750K $2.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest as to one quarter of the shares subject to the option on June 21, 2022, and the balance will vest in 36 successive substantially equal monthly installments thereafter, subject to the reporting person's continuous employment.